SoSTART

Start or STop Anticoagulants Randomised Trial

The main aim of this randomised controlled trial involving people with atrial fibrillation who have had a brain haemorrhage is to determine whether starting full dose oral anticoagulation is superior to avoiding oral anticoagulation for the prevention of all serious vascular events.

 

Chief Investigator: Rustam Al-Shahi Salman

Number and location of participating sites (by region/ country): UK 32 sites (pilot phase), up to 120 sites (main phase)

EudraCT number: 2016-004121-16

ISRCTN number: https://clinicaltrials.gov/ct2/show/NCT03153150

 

Funder: Chest Heart & Stroke Scotland

Start and End date

Of grant award: August 2016 – July 2018

Of recruitment: 

 

Current Status: in set up

Website: http://www.sostart.ed.ac.uk

Contact Details:

Sponsor: ACCORD http://www.accord.ed.ac.uk/

Chief Investigator: Rustam Al-Shahi Salman, Centre for Clinical Brain Sciences (CCBS), FU303i, First Floor, Chancellor's Building, 49 Little France Crescent, Edinburgh. EH16 4SB. Tel +44 (0)131 465 9602

 

ECTU Involvement Statistics / Data base and/or randomisation service

SoSTART trial logo

This article was published on